Skip to main content


Page 2 of 18

  1. The aim of this retrospective study was to compare the diagnostic accuracy of somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of hepatic involvement in neuroendocrine tu...

    Authors: Freba Grawe, Natalie Rosenberger, Maria Ingenerf, Leonie Beyer, Ralf Eschbach, Andrei Todica, Ricarda Seidensticker, Christine Schmid-Tannwald, Clemens C. Cyran, Jens Ricke, Peter Bartenstein, Christoph. J. Auernhammer, Johannes Ruebenthaler and Matthias P. Fabritius
    Citation: Cancer Imaging 2023 23:41
  2. Dual Energy Computed Tomography (DECT) is a technology that allows for viewing computed tomography spectral images. This method, due to ability of presenting specific elements and substances (like water, calci...

    Authors: Adam Daniel Durma, Marek Saracyn, Arkadiusz Zegadło and Grzegorz Kamiński
    Citation: Cancer Imaging 2023 23:39
  3. The advent of next-generation computed tomography (CT)- and magnetic resonance imaging (MRI) opened many new perspectives in the evaluation of tumor characteristics. An increasing body of evidence suggests the...

    Authors: Vitali Koch, Nils Weitzer, Daniel Pinto Dos Santos, Leon D. Gruenewald, Scherwin Mahmoudi, Simon S. Martin, Katrin Eichler, Simon Bernatz, Tatjana Gruber-Rouh, Christian Booz, Renate M. Hammerstingl, Teodora Biciusca, Nicolas Rosbach, Aynur Gökduman, Tommaso D’Angelo, Fabian Finkelmeier…
    Citation: Cancer Imaging 2023 23:38
  4. Neuronavigation of preoperative MRI is limited by several errors. Intraoperative ultrasound (iUS) with navigated probes that provide automatic superposition of pre-operative MRI and iUS and three-dimensional i...

    Authors: Edoardo Mazzucchi, Patrick Hiepe, Max Langhof, Giuseppe La Rocca, Fabrizio Pignotti, Pierluigi Rinaldi and Giovanni Sabatino
    Citation: Cancer Imaging 2023 23:37
  5. Global energy balance is a vital process tightly regulated by the brain that frequently becomes dysregulated during the development of cancer. Glioblastoma (GBM) is one of the most investigated malignancies, b...

    Authors: Irene Guadilla, Sara González, Sebastián Cerdán, Blanca Lizarbe and Pilar López-Larrubia
    Citation: Cancer Imaging 2023 23:36
  6. The efficacy of 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography(PET/CT) in evaluating the neck status in clinically node-negative (cN0) oral squamous cell carcinoma(OSCC) patient...

    Authors: Feng Xu, Liling Peng, Junyi Feng, Xiaochun Zhu, Yifan Pan, Yuhua Hu, Xin Gao, Yubo Ma and Yue He
    Citation: Cancer Imaging 2023 23:34

    The Correction to this article has been published in Cancer Imaging 2023 23:47

  7. Several previous studies demonstrated that the combination of self-expandable metallic stents (SEMS) and 125I seed implantation might prolong stent patency and obtain survival benefits for malignant obstructive j...

    Authors: Ye Sheng, Xiaobo Fu, Guobao Wang, Maoyuan Mu, Weiwei Jiang, Zixiong Chen, Han Qi and Fei Gao
    Citation: Cancer Imaging 2023 23:33
  8. To assess volumetric ablation margins derived from intraoperative pre- and post-ablation MRI after magnetic resonance imaging (MRI)-guided percutaneous cryoablation of renal tumors and explore its correlation ...

    Authors: Nienke S. de Jager, Tim J. van Oostenbrugge, Torben Pätz, Sjoerd F. M. Jenniskens, Jurgen J. Fütterer, Johan F. Langenhuijsen and Christiaan G. Overduin
    Citation: Cancer Imaging 2023 23:31
  9. Early evaluation of the efficacy of first-line chemotherapy combined with bevacizumab in patients with colorectal cancer liver metastasis (CRLM) remains challenging. This study used 2-month post-chemotherapy s...

    Authors: Shenglin Li, Long Yuan, Mengying Yue, Yuan Xu, Suwei Liu, Feng Wang, Xiaoqin Liu, Fengyan Wang, Juan Deng, Qiu Sun, Xianwang Liu, Caiqiang Xue, Ting Lu, Wenjuan Zhang and Junlin Zhou
    Citation: Cancer Imaging 2023 23:30
  10. Hypoperfusion or resultant hypoxia in solid tumours is a main reason for therapeutic resistance. Augmenting the blood perfusion of hypovascular tumours might improve both hypoxia and drug delivery. Cavitation ...

    Authors: Najiao Tang, Jiawei Tang, Junhui Tang, Qiong Zhu, Xiaoxiao Dong, Yi Zhang, Ningshan Li and Zheng Liu
    Citation: Cancer Imaging 2023 23:29
  11. Recently introduced long-axial field-of-view (LAFOV) PET/CT systems represent one of the most significant advancements in nuclear medicine since the advent of multi-modality PET/CT imaging. The higher sensitiv...

    Authors: Ian Alberts, Hasan Sari, Clemens Mingels, Ali Afshar-Oromieh, Thomas Pyka, Kuangyu Shi and Axel Rominger
    Citation: Cancer Imaging 2023 23:28
  12. Radiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate cancer treatment. This study examines the value of prostate-specific membr...

    Authors: Sara Harsini, Don Wilson, Heather Saprunoff, Hayley Allan, Martin Gleave, Larry Goldenberg, Kim N. Chi, Charmaine Kim-Sing, Scott Tyldesley and François Bénard
    Citation: Cancer Imaging 2023 23:27
  13. Carotid artery invasion (CAI) has been demonstrated to be an important prognosticator in some head and neck cancers. This study aimed to examine the prognostic value of radiologic CAI (rCAI) by cervical lympha...

    Authors: Wenze Qiu, Xi Zhong, Jiali Jiang, Laiji Huang, Jiansheng Li, Ronghui Zheng, Zhuochen Cai and Yawei Yuan
    Citation: Cancer Imaging 2023 23:26
  14. Ductal lesions are an important, often overlooked, and poorly understood issue in breast imaging, which have a risk of underlying malignancy ranging from 5 to 23%. Ultrasonography (US), which has largely repla...

    Authors: Bo Wang, Di Yang, Xuan Zhang, XuanTong Gong, Tong Xu, Jie Han, YinPeng Ren, ShuangMei Zou, Lin Li and Yong Wang
    Citation: Cancer Imaging 2023 23:25
  15. This study evaluated the performance of the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) in patients without LI-RADS-defined hepatocellular carcinoma (HCC) risk factors...

    Authors: Zhe Huang, Ping Ping Zhou, Shan Shan Li and Kaiyan Li
    Citation: Cancer Imaging 2023 23:24
  16. To compare different response criteria using computed tomography (CT) and positron emission tomography (PET) in measuring response and survival in the early phase after programmed death-1 (PD-1) blockade monot...

    Authors: Kyoichi Kaira, Ou Yamaguchi, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Shin Yanagisawa, Norimitsu Kasahara, Tetsuya Higuchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Atsuto Mouri, Hisao Imai, Kunihiko Iizuka…
    Citation: Cancer Imaging 2023 23:23
  17. We aimed to prospectively compare the diagnostic performance of gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed Tomography (CECT) for hepatocellular carcinoma (HCC) detection and liver tra...

    Authors: Kartik S. Jhaveri, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar and Gonzalo Sapisochin
    Citation: Cancer Imaging 2023 23:22
  18. To explore the prognostic role of FDG PET/CT maximal standard uptake values of metastatic lesions (SUVmax-M) in patients with de novo metastatic nasopharyngeal carcinoma (mNPC) following palliative chemotherap...

    Authors: Wenbin Yan, Chunhua Sun, Xiaomin Ou and Chaosu Hu
    Citation: Cancer Imaging 2023 23:21
  19. Although some studies have assessed the correlation between computed tomography (CT) features and anaplastic lymphoma kinase (ALK) rearrangement in patients with non-small-cell lung cancer (NSCLC), few have fo...

    Authors: Xiaoming Hou, Han Chen, You Liu, Sandong Gong, Meizi Zhudai and Leilei Shen
    Citation: Cancer Imaging 2023 23:20
  20. Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of raltitrexed-based transarterial chemoembolization (TACE) or drug-eluting beads T...

    Authors: Yonghua Bi, Yang Wang, Wenguang Zhang, Huibin Lu, Jianzhuang Ren and Xinwei Han
    Citation: Cancer Imaging 2023 23:19
  21. Patients with colorectal liver metastases (CRLM) combined with hepatic lymph node (HLN) metastases have a poor prognosis. In this study, we developed and validated a model using clinical and magnetic resonance...

    Authors: Hai-bin Zhu, Da Xu, Xue-Feng Sun, Xiao-Ting Li, Xiao-Yan Zhang, Kun Wang, Bao-Cai Xing and Ying-Shi Sun
    Citation: Cancer Imaging 2023 23:18
  22. Although MRI is a radiation-free imaging modality, it has historically been limited in lung imaging due to inherent technical restrictions. The aim of this study is to explore the performance of lung MRI in de...

    Authors: Felipe Sanchez, Pascal N. Tyrrell, Patrick Cheung, Chinthaka Heyn, Simon Graham, Ian Poon, Yee Ung, Alexander Louie, May Tsao and Anastasia Oikonomou
    Citation: Cancer Imaging 2023 23:17
  23. Appropriate preoperative identification of iCCA subtype is essential for personalized management, so the aim of this study is to investigate the role of MR imaging features in preoperatively differentiating th...

    Authors: Yuyao Xiao, Changwu Zhou, Xiaoyan Ni, Peng Huang, Fei Wu, Chun Yang and Mengsu Zeng
    Citation: Cancer Imaging 2023 23:15
  24. The purpose of this study was to explore whether incorporating the peritumoral region to train deep neural networks could improve the performance of the models for predicting the prognosis of NPC.

    Authors: Song Li, Xia Wan, Yu-Qin Deng, Hong-Li Hua, Sheng-Lan Li, Xi-Xiang Chen, Man-Li Zeng, Yunfei Zha and Ze-Zhang Tao
    Citation: Cancer Imaging 2023 23:14
  25. To analyse the predictive effect of a nomogram combining dual-layer spectral computed tomography (DSCT) quantitative parameters with typical radiological features in distinguishing benign micro-nodule from thy...

    Authors: Zuhua Song, Qian Li, Dan Zhang, Xiaojiao Li, Jiayi Yu, Qian Liu, Zongwen Li, Jie Huang, Xiaodi Zhang and Zhuoyue Tang
    Citation: Cancer Imaging 2023 23:13
  26. Metastatic bone disease (MBD) is the most common form of metastases, most frequently deriving from prostate cancer. MBD is screened with bone scintigraphy (BS), which have high sensitivity but low specificity ...

    Authors: Abdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, Flore Belmans, Fabio Bottari, Turkey Refaee, Pierre Lovinfosse, Alexandre Jadoul, Celine Derwael, Fabian Hertel, Henry C. Woodruff, Helle D. Zacho, Sean Walsh, Wim Vos, Mariaelena Occhipinti, François-Xavier Hanin…
    Citation: Cancer Imaging 2023 23:12
  27. Accurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this study was to compare the diagnostic performance of FDG PET/MRI versus FDG ...

    Authors: Vijay Mistry, Justin R. Scott, Tzu-Yang Wang, Peter Mollee, Kenneth A. Miles, W. Phillip Law and Greg Hapgood
    Citation: Cancer Imaging 2023 23:11
  28. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line therapy for non-small cell lung cancer (NSCLC) with EGFR mutations. Approximately half of the patients with EGFR-muta...

    Authors: Chia-Feng Lu, Chien-Yi Liao, Heng-Sheng Chao, Hwa-Yen Chiu, Ting-Wei Wang, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen and Yu-Te Wu
    Citation: Cancer Imaging 2023 23:9
  29. The evaluation of treatment response according to METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) criteria is an important but time-consuming task for patients with advanced prostate canc...

    Authors: Xiang Liu, Zemin Zhu, Kexin Wang, Yaofeng Zhang, Jialun Li, Xiangpeng Wang, Xiaodong Zhang and Xiaoying Wang
    Citation: Cancer Imaging 2023 23:7
  30. Deep-learning-based computer-aided diagnosis (DL-CAD) systems using MRI for prostate cancer (PCa) detection have demonstrated good performance. Nevertheless, DL-CAD systems are vulnerable to high heterogeneiti...

    Authors: Lei Hu, Caixia Fu, Xinyang Song, Robert Grimm, Heinrich von Busch, Thomas Benkert, Ali Kamen, Bin Lou, Henkjan Huisman, Angela Tong, Tobias Penzkofer, Moon Hyung Choi, Ivan Shabunin, David Winkel, Pengyi Xing, Dieter Szolar…
    Citation: Cancer Imaging 2023 23:6
  31. To investigate the role of preoperative body composition analysis for muscle and adipose tissue distribution on long-term oncological outcomes in patients with middle and low rectal cancer (RC) who received cu...

    Authors: Jiyang Liu, Xiongfeng Yu, Xueqing Huang, Qingquan Lai and Jieyun Chen
    Citation: Cancer Imaging 2023 23:5
  32. PET/MRI is an emerging imaging modality which enables the evaluation and quantification of biochemical processes in tissues, complemented with accurate anatomical information and low radiation exposure. In the...

    Authors: Stefan Prado-Wohlwend, Mónica Ballesta-Moratalla, Irene Torres-Espallardo, María Isabel del Olmo-García, Pilar Bello-Arques, Consuelo Olivas-Arroyo and Juan Francisco Merino-Torres
    Citation: Cancer Imaging 2023 23:4
  33. Early diagnosis of prostate cancer improves its prognosis, while it is essential to upgrade screening tools. This study aimed to explore the value of a novel functional magnetic resonance imaging (MRI) techniq...

    Authors: Lu Yang, Lei Wang, Yuchuan Tan, Hanli Dan, Peng Xian, Yipeng Zhang, Yong Tan, Meng Lin and Jiuquan Zhang
    Citation: Cancer Imaging 2023 23:3
  34. The aim of this study is to investigate the impact of 18F-FDG PET/CT on prognosis of stage II invasive ductal carcinoma (IDC) of the breast primarily treated with surgery.

    Authors: Hye Lim Park, Sea-Won Lee, Ji Hyung Hong, Jieun Lee, Ahwon Lee, Soo Jin Kwon, Sonya Youngju Park and Ie Ryung Yoo
    Citation: Cancer Imaging 2023 23:2
  35. A comparative retrospective study to assess the impact of PSMA Ligand PET/MRI ([68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 PET/MRI) as a new method of target delineation compared to conventional imaging on whole-...

    Authors: Lin-Lin Liu, Lei-Lei Zhu, Zhen-Guo Lu, Jun-Die Sun, Jun Zhao, Hai-Feng Wang and Zuo-Lin Xiang
    Citation: Cancer Imaging 2023 23:1
  36. The injection activity of tracer, acquisition time, patient-specific photon attenuation, and large body mass, can influence on image quality. Fixed acquisition time and body mass related injection activity in ...

    Authors: Jie Xiao, Haojun Yu, Xiuli Sui, Guobing Liu, Yanyan Cao, Zhao Yanzhao, Yiqiu Zhang, Pengcheng Hu, Dengfeng Cheng and Hongcheng Shi
    Citation: Cancer Imaging 2022 22:78
  37. To evaluate the performance of diffusion-relaxation correlation spectrum imaging (DR-CSI) with support vector machine (SVM) in detecting prostate cancer (PCa).

    Authors: Xiaobin Wei, Li Zhu, Yanyan Zeng, Ke Xue, Yongming Dai, Jianrong Xu, Guiqin Liu, Fang Liu, Wei Xue, Dongmei Wu and Guangyu Wu
    Citation: Cancer Imaging 2022 22:77
  38. To find semi-quantitative and quantitative Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and non-malignant lymphoid tissue (bone marrow and spleen) for Progression Free...

    Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad and Håkan Ahlström
    Citation: Cancer Imaging 2022 22:76

    The Correction to this article has been published in Cancer Imaging 2023 23:46

  39. Texture analysis derived from computed tomography (CT) can provide clinically relevant imaging biomarkers. Node-RADS is a recently proposed classification to categorize lymph nodes in radiological images. The ...

    Authors: Hans-Jonas Meyer, Benedikt Schnarkowski, Johanna Pappisch, Teresa Kerkhoff, Hubert Wirtz, Anne-Kathrin Höhn, Sebastian Krämer, Timm Denecke, Jakob Leonhardi and Armin Frille
    Citation: Cancer Imaging 2022 22:75
  40. To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate...

    Authors: Adalgisa Guerra, Filipe Caseiro Alves, Kris Maes, Steven Joniau, João Cassis, Rui Maio, Marília Cravo and Helena Mouriño
    Citation: Cancer Imaging 2022 22:74

    The Correction to this article has been published in Cancer Imaging 2023 23:32

  41. Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radio...

    Authors: E. Lopci, N. Aide, A. Dimitrakopoulou-Strauss, L. Dercle, A. Iravani, R. D. Seban, C. Sachpekidis, O. Humbert, O. Gheysens, A. W. J. M. Glaudemans, W. A. Weber, A. D. Van den Abbeele, R. L. Wahl, A. M. Scott, N. Pandit-Taskar and R. J. Hicks
    Citation: Cancer Imaging 2022 22:73
  42. High-risk differentiated thyroid cancer (DTC) needs effective early prediction tools to improving clinical management and prognosis. This cohort study aimed to investigate the prognostic impact of 99mTc-PEG4-E[PE...

    Authors: Yiqian Liang, Xi Jia, Yuanbo Wang, Yan Liu, Xiaobao Yao, Yanxia Bai, Peng Han, Si Chen, Aimin Yang and Rui Gao
    Citation: Cancer Imaging 2022 22:72
  43. Biologically targeted radiation therapy treatment planning requires voxel-wise characterisation of tumours. Dynamic contrast enhanced (DCE) DCE MRI has shown promise in defining voxel-level biological characte...

    Authors: Hayley M. Reynolds, Sirisha Tadimalla, Yu-Feng Wang, Maryam Montazerolghaem, Yu Sun, Scott Williams, Catherine Mitchell, Mary E. Finnegan, Declan G. Murphy and Annette Haworth
    Citation: Cancer Imaging 2022 22:71
  44. This review describes the main benefits of using long axial field of view (LAFOV) PET in clinical applications. As LAFOV PET is the latest development in PET instrumentation, many studies are ongoing that expl...

    Authors: Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, Johannes H. van Snick, Mostafa Roya, Dik ten Hove, Adrienne H. Brouwers, Adriaan A. Lammertsma, Walter Noordzij, Rudi A.J.O. Dierckx, Riemer H.J.A. Slart and Andor W.J.M. Glaudemans
    Citation: Cancer Imaging 2022 22:69

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.636 - SNIP (Source Normalized Impact per Paper)
    1.231 - SJR (SCImago Journal Rank)

    2022 Speed
    14 days submission to first editorial decision for all manuscripts (Median)
    122 days submission to accept (Median)

    2022 Usage 
    454 Altmetric mentions 

Download journal leaflet